Fig. 1 · Structure
Documents & Downloads
ERG240
BCAT1 Inhibitor
ERG240 is a selective inhibitor of branched-chain amino acid aminotransferase 1 (BCAT1). This compound plays a crucial role in regulating branched-chain amino acid metabolism, making it pertinent in cancer research, as well as investigations into rheumatoid arthritis and bone diseases. ERG240 offers valuable insights into the therapeutic potential of targeting BCAT1 in various pathological conditions.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 1415683-79-2 |
| Applications | BCAT1 Inhibitor |
| Formula | C7H11NaO3 |
| Molecular Weight | 166.15 |
| SMILES | O=C(CCC(C)C(C)=O)O[Na] |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.